Olsen, LeighAnne, McGinnis, J. Michael. "Appendix A: Workshop Agenda." Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary. Washington, DC: The National Academies Press, 2010.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches – Workshop Summary
• Engaging consumers
Kathy Hudson, Johns Hopkins University
Respondent: Jerry Avorn, Harvard Medical School
General discussion
3:15
SESSION 6: ORGANIZING THE RESEARCH COMMUNITY FOR CHANGE—DISCUSSION PANEL
What guiding principles are important in refining the clinical effectiveness research paradigm and in fostering the necessary changes? What issues need to be addressed in integrating trials into a lifecycle approach to evidence development? What expertise and training might be needed? What are some of the political challenges?
Chair: J. Michael McGinnis, Institute of Medicine
Panel discussion
Panel: Alan M. Krensky (NIH), Mark B. McClellan(Brookings Institution), Garry Neil (Johnson & Johnson),John Niederhuber (NCI), Lewis Sandy (United HealthCare)
4:30
CONCLUDING SUMMARY REMARKS AND ADJOURNMENT
J. Michael McGinnis, Institute of Medicine
Workshop Planning Committee
Robert M. Califf, MD, Duke Clinical Research Institute, Duke University
Lynn Etheredge, George Washington University
Kim Gilchrist, MD, AstraZeneca LP
Bryan Luce, PhD, MBA, United Biosource Corporation
Jonathan Perlin, MD, PhD, MSHA, FACP, HCA Inc.
Richard Platt, MD, MS, Harvard Medical School and Harvard Pilgrim
